Cariprazine DP-4 Impurity - Request Quote
Cariprazine DP-4 Impurity
| SZ CAT No: | SZ-C058058 |
| CAS No | NA |
| Mol.F. | C21H31Cl3N4O |
| Mol.Wt. | 461.9 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Cariprazine DP-4 Impurity is chemically 1,1-Dimethyl-3-(4-(2-(4-(2,3,4-trichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)urea. Cariprazine DP-4 Impurity is supplied with detailed characterization data compliant with regulatory guideline. Cariprazine DP-4 Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cariprazine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Cariprazine DP-4 Impurity
Purchase Cariprazine DP-4 Impurity
Cariprazine DP-4 Impurity suppliers
Cariprazine DP-4 Impurity manufacturers
Cariprazine DP-4 Impurity price
Order Cariprazine DP-4 Impurity
Enquire Cariprazine DP-4 Impurity
Cariprazine DP-4 Impurity cost
Cariprazine DP-4 Impurity Supplier
Cariprazine DP-4 Impurity Distributor
Cariprazine DP-4 Impurity for Method Validation
Cariprazine Reference Standard
Cariprazine DP-4 Impurity for ANDA Filing
Cariprazine DP-4 Impurity for Forced Degradation Studies
Cariprazine DP-4 Impurity Identification Standards
Cariprazine DP-4 Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


